Home › Funds › Rosalind Advisors, Inc. › GRCE
Rosalind Advisors, Inc. position in GRCE
GRACE THERAPEUTICS INC · Health Care
Rosalind Advisors, Inc. reported holding 476,190 shares of GRCE (GRACE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.42% of its reported portfolio and ranking #29 among its reported holdings. Rosalind Advisors, Inc. first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rosalind Advisors, Inc.'s GRCE position evolved
Rosalind Advisors, Inc. first disclosed a stake in GRCE in Q3 2026 at 476,190 shares (US$1.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 476.19K | $1.02M | New |
About GRCE and 13F data
GRCE (GRACE THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in GRCE. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Rosalind Advisors, Inc.
FAQ
How long has Rosalind Advisors, Inc. held GRCE?
Rosalind Advisors, Inc. has disclosed GRCE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Rosalind Advisors, Inc.'s current position in GRCE?
As of Q3 2026, Rosalind Advisors, Inc. holds 476.19K shares of GRCE (GRACE THERAPEUTICS INC), valued at $1.02M, representing 0.42% of its reported portfolio and ranking #29.
Has Rosalind Advisors, Inc. been buying or selling GRCE?
In the latest 13F filing (Q3 2026), Rosalind Advisors, Inc. newly opened its position in GRCE.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.